Glucagon-Like Peptide-1 Receptor Agonist Prevented the Progression of Hepatocellular Carcinoma in a Mouse Model of Nonalcoholic Steatohepatitis

Glucagon-like peptide-1 (GLP-1) receptor agonists are used to treat diabetes, but their effects on nonalcoholic steatohepatitis (NASH) and the development of hepatocellular carcinoma (HCC) remain unclear. In this study, mice with streptozotocin- and high-fat diet-induced diabetes and NASH were subcu...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Int J Mol Sci
Main Authors: Kojima, Motoyasu, Takahashi, Hirokazu, Kuwashiro, Takuya, Tanaka, Kenichi, Mori, Hitoe, Ozaki, Iwata, Kitajima, Yoichiro, Matsuda, Yayoi, Ashida, Kenji, Eguchi, Yuichiro, Anzai, Keizo
פורמט: Artigo
שפה:Inglês
יצא לאור: MDPI 2020
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7460814/
https://ncbi.nlm.nih.gov/pubmed/32785012
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21165722
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים